Has BrainChip Holdings (ASX: BRN) Broken Its Downtrend and Started Building a New Support Base?
BrainChip develops low-power edge AI chips via its Akida platform. Recent momentum reflects licensing and product roadmap optimism, but weak revenue, losses, and dilution remain risks. Technically, BRN has broken its downtrend and is testing support near 0.16 to 0.17.
WiseTech Global Drops Sharply as Investors Rush for the Exit
WiseTech Global shares have fallen sharply amid bearish sentiment and heavy selling pressure. The logistics software company continues to expand its CargoWise platform and invest in AI and digital trade solutions, but investors remain cautious as the stock trades near multi-month lows.
Artrya (ASX: AYA) Pulls Back After Testing Fresh 52-Week Highs
Artrya (ASX: AYA) is consolidating after a strong rally as investors assess its U.S. expansion, FDA progress, and commercial rollout of the AI-powered Salix platform. Despite the pullback, growing adoption and clinical milestones continue to support its long-term growth outlook.
Appen (ASX: APX) - One of the few AI stocks on the ASX with a currently rising share price
Appen Limited (ASX: APX), founded in 1996 and listed since 2015, is an Australian AI data specialist providing dataset sourcing, annotation, and model evaluation. Operating the Global Services and New Markets segments, it serves major tech clients across multiple industries, leveraging a 1M+ global workforce that spans 180+ languages in 130 countries.
Unith (ASX: UNT) Share Price Wobbles Near Yearly Lows Amid Weak Momentum in AI Sector
Unith (ASX: UNT) remains under pressure near yearly lows as weak momentum and cautious sentiment weigh on the AI microcap, despite progress in its real-time Streaming Avatars technology and improving financial trends. Traders remain focused on key support near A$0.0065 amid ongoing volatility.
